Drug Storages Abundant

Share

The FDA released the list of medicines which are in demand because of companies running short in manufacturing. Of these shortages, the most alarming are the shortages of cancer drugs that are causing many patients to postpone chemotherapy.

These scarcities are blamed on increased demand, manufacturing problems, and shortage in active ingredients. Many cancer drugs are a combination of drugs which come from different companies. Hence, if one company fails to produce the required quantity of the needed drug, the final drug falls short of required production. Some of the major pharmaceutical giants like Merck (NYSE:MRK), GlaxoSmithKline (NYSE:GSK), Novartis AG (NYSE:NVS), Pfizer Inc. (NYSE:PFE), etc., are required to speed up production.

Related posts:

  1. Finding The Source of HIV
  2. GlaxoSmithKline sells Penicillin Plants
  3. Bird Flu Resurfaces
  4. Pfizer’s Help With Heart Disease
  5. Lowering Cholesterol Getting Easier



Disclaimer: This article is for informational purposes only and does not constitute financial advice. We are not financial professionals. The authors and/or site operators may hold positions in the companies or assets mentioned. Always do your own research before making financial decisions.